The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

Authors
Citation
H. Kalant, The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs, CAN MED A J, 165(7), 2001, pp. 917-928
Citations number
191
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
CANADIAN MEDICAL ASSOCIATION JOURNAL
ISSN journal
08203946 → ACNP
Volume
165
Issue
7
Year of publication
2001
Pages
917 - 928
Database
ISI
SICI code
0820-3946(20011002)165:7<917:TPATO">2.0.ZU;2-A
Abstract
"ECSTASY" (MDMA) AND RELATED DRUGS ARE AMPHETAMINE DERIVATIVES that also ha ve some of the pharmacological properties of mescaline. They have become po pular with participants in "raves," because they enhance energy, endurance, sociability and sexual arousal. This vogue among teenagers and young adult s, together with the widespread belief that "ecstasy" is a safe drug, has l ed to a thriving illicit traffic in it. But these drugs also have serious t oxic effects, both acute and chronic, that resemble those previously seen w ith other amphetamines and are caused by an excess of the same sympathomime tic actions for which the drugs are valued by the users. Neurotoxicity to t he serotonergic system in the brain can also cause permanent physical and p sychiatric problems. A detailed review of the literature has revealed over 87 "ecstasy"-related fatalities, caused by hyperpyrexia, rhabdomyolysis, in travascular coagulopathy, hepatic necrosis, cardiac arrhythmias, cerebrovas cular accidents, and drug-related accidents or suicide. The toxic or even f atal dose range overlaps the range of recreational dosage. The available ev idence does not yet permit an accurate assessment of the size of the proble m presented by the use of these drugs.